US2006115844A1PendingUtilityA1

Enhanced amplifiability of minute fixative-treated tissue samples, minute stained cytology samples, and other minute sources of DNA

Individually held — no corporate assignee on recordPriority: Oct 22, 2004Filed: Oct 24, 2005Published: Jun 1, 2006
Est. expiryOct 22, 2024(expired)· nominal 20-yr term from priority
G01N 33/57525Y02A90/10C12Q 1/6806G16H 50/30C12Q 2600/154C12Q 2600/112C12Q 1/6827C12Q 2600/156C12Q 2600/118C12Q 2600/106C12Q 1/6886
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The specification provides materials and methods for enhancing the amplifiability of nucleic acids that are present in minute amounts. Preferably, the materials and methods are utilized in combination with pathology techniques to amplify nucleic acids obtained from fixative and/or stained tissue or cell samples. The amplified nucleic acids can then be utilized for rendering a diagnosis or prognosis to the subject from which the tissue or cellular sample was obtained.

Claims

exact text as granted — not AI-modified
1 . A kit for amplification of a nucleic acid from a sample with low nucleic acid concentration comprising: (a) a buffer comprising a nonionic detergent; (b) a proteinase; (c) XCl 2 , wherein X is magnesium or manganese; and (d) sucrose; and wherein XCl 2  and sucrose when admixed with the sample for amplification of DNA have a final concentration of about 5 mM to about 10 mM XCl 2  and about 5 gram percent to about 15 gram percent sucrose.  
     
     
         2 . The kit of  claim 1 , wherein the sample is fixative-treated, fixative-treated and stained, a liquid cytology, or a liquid biological sample.  
     
     
         3 . The kit of  claim 1 , wherein the nucleic acid is DNA.  
     
     
         4 . The kit of  claim 1 , wherein the nonionic detergent is Nonidet P40 (NP-40), Tween, Triton X, or Nikkol.  
     
     
         5 . The kit of  claim 4 , wherein the nonionic detergent is present in the amount of about 0.1% to about 3.0%.  
     
     
         6 . The kit of  claim 5 , wherein the nonionic detergent is Nonidet P40.  
     
     
         7 . The kit of  claim 4 , wherein the nonionic detergent is Nonidet P40 and is present in an amount of about 1.0%.  
     
     
         8 . The kit of  claim 1 , wherein the proteinase is proteinase K, pronase, subtilisin, thermolysin, papain, or a combination thereof.  
     
     
         9 . The kit of  claim 8 , wherein the proteinase or proteinase combination is present in the amount of about 0.1% to about 3.0%.  
     
     
         10 . The kit of  claim 9 , wherein the proteinase is proteinase K.  
     
     
         11 . The kit of  claim 8 , wherein the proteinase is proteinase K and is present in an amount of about 1 mg/mL to about 5 mg/mL.  
     
     
         12 . The kit of  claim 11 , wherein the proteinase K is present in the amount of about 2 mg/mL.  
     
     
         13 . The kit of  claim 1 , wherein XCl 2  is MgCl 2 .  
     
     
         14 . The kit of  claim 1 , wherein XCl 2  is MgCl 2  and is present in the amount of about 6.0 mM to about 10.0 mM.  
     
     
         15 . The kit of  claim 14 , wherein the MgCl 2  is present in the amount of about 8.0 mM.  
     
     
         16 . The kit of  claim 1 , wherein the sucrose is present in the amount of about 12 gram percent.  
     
     
         17 . A method for amplification of DNA of a sample with low DNA concentration comprising: 
 (a) combining a sample of cellular containing material and an aqueous buffer comprising a nonionic detergent;    (b) adding a proteinase to the buffer and the sample and incubating the buffer, the sample, and proteinase at a temperature suitable for proteinase digestion of protein;    (c) deactivating the proteinase;    (d) adding sucrose to the sample being amplified to a final concentration of about five gram percent to about 15 gram percent; and    (e) adding XCl 2  to the sample being amplified to a final concentration of about 6.0 mM to about 10.0 mM.    
     
     
         18 . The method of  claim 17 , wherein about a 1 μL to about a 5 μL sample is amplified.  
     
     
         19 . The method of  claim 17 , wherein the buffer further comprises sodium chloride, EDTA, and Tris.  
     
     
         20 . The method of  claim 17 , wherein the sample is fixative-treated, stained, fixative-treated and stained, a liquid cytology, or a biological liquid specimen.  
     
     
         21 . The method of  claim 17 , wherein the nonionic detergent is Nonidet P40 (NP-40), Tween, Triton X, or Nikkol.  
     
     
         22 . The method of  claim 21 , wherein the nonionic detergent is NP-40 and is present in the amount of about 1.0%.  
     
     
         23 . The method of  claim 17 , wherein the proteinase is proteinase K, pronase, subtilisin, thermolysin, papain, or a combination thereof.  
     
     
         24 . The method of  claim 23 , wherein the proteinase is proteinase K and is present in an amount of about 1.0 mg/mL to about 5.0 mg/mL.  
     
     
         25 . The method of  claim 24 , wherein the proteinase K is present in the amount of about 2.0 mg/mL.  
     
     
         26 . The method of  claim 17 , wherein said XCl 2  is MgCl 2  or MnCl 2 .  
     
     
         27 . The method of  claim 26 , wherein the XCl 2  is MgCl 2  and is present in the amount of about 5.0 mM to about 10.0 mM.  
     
     
         28 . The method of  claim 17 , wherein sucrose is present in the amount of about 12.0 gram percent.  
     
     
         29 . The method of  claim 17 , wherein the proteinase is proteinase K and is present in the amount of about 2 mg/mL; the sucrose is present in the amount of about 12.0 gram percent; the nonionic detergent is nonidet P-40, which is present in the amount of about 1%; and XCl 2  is MgCl 2  and is present in the amount of about 8.0 mM.

Join the waitlist — get patent alerts

Track US2006115844A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.